Heart Attack Definition Changes

A New Standard for Heart Attacks

A major change in cardiovascular medicine is set to reshape how heart attacks are diagnosed and classified worldwide. The European Society of Cardiology, American College of Cardiology, American Heart Association and World Heart Federation have jointly introduced the Fifth Universal Definition of Myocardial Infarction, replacing the numerical system that has been used since 2018.

The new framework divides myocardial infarctions into three broad categories: primary, secondary and procedure-related heart attacks. The aim is to make diagnosis more closely reflect the underlying cause of the cardiac injury and to make the classification easier to apply consistently in hospitals and research.

One of the most important changes concerns women. Certain forms of heart attack, including coronary artery spasm, coronary embolism and spontaneous coronary artery dissection, occur disproportionately among women but have historically been more difficult to identify and classify. The new definition gives these conditions greater recognition within the primary myocardial infarction category.

The updated approach also introduces sex-specific thresholds for cardiac troponin, a protein released when heart muscle is damaged. Previous diagnostic approaches often relied on thresholds that did not adequately account for biological differences between men and women, potentially contributing to underdiagnosis among female patients.

The change is significant because timely diagnosis is critical in heart attacks. A missed or delayed diagnosis can postpone appropriate treatment and increase the risk of serious complications. By incorporating the underlying mechanism of the heart attack and improving the interpretation of diagnostic tests, the new framework aims to make treatment more precise.

The new definition also encourages the use of cardiac imaging to establish the cause of myocardial infarction and introduces updated terminology for conditions such as myocardial infarction with non-obstructive coronary arteries.

The broader significance extends beyond Europe. Because the framework has been developed jointly by major cardiovascular organizations representing different regions, it is intended to create a more consistent global approach to diagnosis, research and health reporting.

For women in particular, the reform could mark an important shift in cardiovascular medicine. A diagnostic system that better reflects biological differences between patients may help reduce long-standing gaps in recognition and treatment.

The real impact, however, will depend on how quickly hospitals and healthcare systems adopt the new standards. The publication of a new definition is only the first step; its success will ultimately be measured by whether patients receive faster, more accurate and more appropriate treatment.